Marcela M. Cordero Garcia

Array ( [id] => 6465184 [patent_doc_number] => 20100190710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'IL-23 RECEPTOR ANTAGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/666028 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25675 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190710.pdf [firstpage_image] =>[orig_patent_app_number] => 12666028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485572 [patent_doc_number] => 07902329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Oligopeptide tyrosinase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/146070 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13328 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902329.pdf [firstpage_image] =>[orig_patent_app_number] => 12146070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523052 [patent_doc_number] => 08026208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Peptide tyrosinase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/146095 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14164 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026208.pdf [firstpage_image] =>[orig_patent_app_number] => 12146095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297338 [patent_doc_number] => 20090012264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Microwave-Assisted Peptide Synthesis' [patent_app_type] => utility [patent_app_number] => 12/143979 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8593 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012264.pdf [firstpage_image] =>[orig_patent_app_number] => 12143979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248684 [patent_doc_number] => 20100137197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'LYOPHILIZED ANTI-FUNGAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/666426 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7934 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137197.pdf [firstpage_image] =>[orig_patent_app_number] => 12666426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840588 [patent_doc_number] => 20080281074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Compounds and Methods for Reversible Modification of Biologically Active Molecules' [patent_app_type] => utility [patent_app_number] => 12/140751 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 41204 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281074.pdf [firstpage_image] =>[orig_patent_app_number] => 12140751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637074 [patent_doc_number] => 20100173834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/664695 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15061 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173834.pdf [firstpage_image] =>[orig_patent_app_number] => 12664695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6349400 [patent_doc_number] => 20100249038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ANTAGONISTS OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE)' [patent_app_type] => utility [patent_app_number] => 12/664056 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15933 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249038.pdf [firstpage_image] =>[orig_patent_app_number] => 12664056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270943 [patent_doc_number] => 20090074719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Peptides, Peptidomimetics and Small Molecule Inhibitors of the Epstein-Barr Virus Mediated Fusion and Entry Process' [patent_app_type] => utility [patent_app_number] => 12/137842 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13844 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074719.pdf [firstpage_image] =>[orig_patent_app_number] => 12137842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596632 [patent_doc_number] => 07982066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'High protein supplement' [patent_app_type] => utility [patent_app_number] => 12/135933 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 62524 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982066.pdf [firstpage_image] =>[orig_patent_app_number] => 12135933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429069 [patent_doc_number] => 20090088379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'RECONSTITUTED SURFACTANTS HAVING IMPROVED PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/131373 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6798 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088379.pdf [firstpage_image] =>[orig_patent_app_number] => 12131373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 127939 [patent_doc_number] => RE041252 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-04-20 [patent_title] => 'Peptidyl prodrugs and linkers and stabilizers useful therefor' [patent_app_type] => reissue [patent_app_number] => 12/126731 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 3 [patent_no_of_words] => 30040 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041252.pdf [firstpage_image] =>[orig_patent_app_number] => 12126731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533435 [patent_doc_number] => 08309590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Triazol compounds for treating biofilm formation' [patent_app_type] => utility [patent_app_number] => 12/600667 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5383 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275124 [patent_doc_number] => 20100256044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'PEPTIDES WITH IMPROVED PROPERTIES HAVING THE BIOLOGICAL ACTIVITY OF VASOACTIVE INTESTINAL PEPTIDE (VIP) AND THEIR USE FOR THE TREATMENT OF LUNG DISEASES' [patent_app_type] => utility [patent_app_number] => 12/451685 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7935 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256044.pdf [firstpage_image] =>[orig_patent_app_number] => 12451685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492441 [patent_doc_number] => 20100093611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/451539 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12007 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093611.pdf [firstpage_image] =>[orig_patent_app_number] => 12451539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336816 [patent_doc_number] => 20090053280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'COATING STENTS WITH CYCLIC RGD PEPTIDES OR MIMETICS' [patent_app_type] => utility [patent_app_number] => 12/121568 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9366 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053280.pdf [firstpage_image] =>[orig_patent_app_number] => 12121568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455209 [patent_doc_number] => 08716217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof' [patent_app_type] => utility [patent_app_number] => 12/149542 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9403 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12149542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629670 [patent_doc_number] => 08361740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Peptide standards' [patent_app_type] => utility [patent_app_number] => 12/597872 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12770 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713262 [patent_doc_number] => 08399402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Polypeptide as standard for proteome analysis' [patent_app_type] => utility [patent_app_number] => 12/599960 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4410 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949086 [patent_doc_number] => 20080305212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties' [patent_app_type] => utility [patent_app_number] => 12/103514 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21609 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305212.pdf [firstpage_image] =>[orig_patent_app_number] => 12103514 [rel_patent_id] =>[rel_patent_doc_number] =>)